HZNP - Horizon Therapeutics ticks higher as Amgen end date extended until December
2023-09-12 07:48:40 ET
More on Horizon Therapeutics
- Seeking Alpha’s Quant Rating on Horizon Therapeutics
- Horizon Therapeutics: Can Investors Profit From Amgen Deal Confusion?
- Improved Outlook For Horizon Therapeutics And Amgen
- Irish High Court hearing for Horizon's $28B sale to Amgen set for Oct. 5
- Horizon Therapeutics gains afer FTC settles with Amgen over $28B deal (update)
- Court hearing on FTC's challenge to Horizon/Amgen rescheduled until next week
- Biggest stock movers today: Hawaiian Electric, RPT Realty, VinFast Auto and more
For further details see:
Horizon Therapeutics ticks higher as Amgen end date extended until December